Filing Details
- Accession Number:
- 0001179110-18-004030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-12 13:33:43
- Reporting Period:
- 2018-03-09
- Accepted Time:
- 2018-03-12 13:33:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509415 | P Christopher Leamon | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Vice President Of Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-03-09 | 5,036 | $9.07 | 143,470 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the sale of 5,036 shares at a sale price per share of $9.07. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.